e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Defi Technologies, Inc. - Common Stock
Thunder Bridge Capital Partners IV, Inc. - Unit
Edit Watchlist
Indicators
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Microbot Medical Inc. - Common Stock
(NQ:
MBOT
)
0.6939
+0.0049 (+0.71%)
Delayed Quote
Updated: 12:44 PM EST, Nov 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Microbot Medical Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
US Session Top Movers: Double-Digit Gainers and Losers
↗
November 16, 2026
Via
Chartmill
Top US Stock Movers in Today's Session: OPENL Up 106.0%, FCUV Down 38.7%
↗
November 16, 2026
Via
Chartmill
Opening Gap Movers: November 16, 2026 Session
↗
November 16, 2026
Via
Chartmill
Premarket Movers on Nov. 16, 2026: Gainers and Decliners
↗
November 16, 2026
Via
Chartmill
Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating Achievements
November 16, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Strengthens IP Portfolio as it Continues to Establish Infrastructure to Support Future Commercialization Expansion
November 05, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System
October 27, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Attending Key Medical Conference to Engage with Decision-makers as it Continues to Expand Presence Across the U.S.
October 23, 2026
Opportunity to Connect with Hospital Administrators and Physicians to Foster Expanded Adoption of the LIBERTY System
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio
October 20, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
October 06, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Highlights Growth Strategy
September 25, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
August 11, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
July 21, 2026
Company CEO has been a featured presenter at several recent industry events on the emergence of endovascular robotics as expert speaking opportunities raising profile of the Company throughout medtech...
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
July 07, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
June 30, 2026
Expanding manufacturing capabilities is part of the Company’s cost reduction strategy and supports global expansion
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
June 25, 2026
Innovative Start-Up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
June 23, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
June 16, 2026
The agreement with Lovell Government Services creates opportunities to sell the LIBERTY® System at more than 2,000 government facilities, including those administered by the U.S. Department of Veterans...
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
June 09, 2026
First Midwest-based account reflects continued execution of the Company's Full Market Release strategy and expansion into additional U.S. territories
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
June 02, 2026
A leading academic center becomes the first user in the Southeast, Mid-Atlantic region
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
May 26, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
May 15, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
May 14, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
May 05, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
April 30, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
April 22, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference
April 14, 2026
The presentation will be webcast live on April 15 at 10:15 a.m. ET. Continued Engagement with Healthcare Institutions Reflects Rising Momentum
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
April 13, 2026
Successful Execution of the Limited Market Release (LMR) Includes Adoption by Globally Recognized Healthcare Systems in the U.S. Market and Demonstrates Broad Market Scalability in Key Endovascular...
From
Microbot Medical Inc.
Via
GlobeNewswire
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
March 26, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
March 24, 2026
From
Microbot Medical Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.